EDNRA and pulmonary arterial hypertension: The presence of elevated anti-AT1R and anti-ETAR Ab levels in sera of SSc patients correlates with an increased risk for the development of lung fibrosis, pulmonary arterial hypertension (PAH), as well as with mortality, as demonstrated previously [3].